The Company - Additional Information (Details) - $ / shares |
Mar. 31, 2026 |
Feb. 12, 2026 |
Dec. 31, 2025 |
|---|---|---|---|
| Organization, Consolidation and Presentation of Financial Statements [Line Items] | |||
| Ordinary shares, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
| Avadel Pharmaceuticals Plc [Member] | |||
| Organization, Consolidation and Presentation of Financial Statements [Line Items] | |||
| Issued ordinary share | $ 21 | ||
| Ordinary shares, par value (in dollars per share) | 0.01 | ||
| Potential additional cash payment per share upon achievement of certain specific milestone | $ 1.5 |